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Abstract
Background: Because high blood pressure, altered lipid levels, obesity, and diabetes so frequently
occur together, they are sometimes collectively referred to as the metabolic syndrome. While
there have been many studies of each metabolic syndrome trait separately, few studies have
attempted to analyze them combined, i.e., as one composite variable, in quantitative trait linkage or
association analysis. We used genotype and phenotype data from the Framingham Heart Study to
perform a full-genome scan for quantitative trait loci underlying the metabolic syndrome.
Results: Heritability estimates for all of the covariate-adjusted and age- and gender-standardized
individual traits, and the composite metabolic syndrome trait, were all fairly high (0.39–0.62), and
the composite trait was among the highest at 0.61. The composite trait yielded no regions with
suggestive linkage by Lander and Kruglyak's criteria, although there were several noteworthy
regions for individual traits, some of which were also observed for the composite variable.
Conclusion: Despite its high heritability, the composite metabolic syndrome trait variable did not
increase the power to detect or localize linkage peaks in this sample. However, this strategy and
related methods of combining correlated individual traits deserve further investigation, particularly
in settings with complex causal pathways.
Background
Coronary artery disease (CAD) and related cardiovascular
diseases are genetically complex and heterogeneous. Sev-
eral identified risk factors for CAD, including diabetes
mellitus, arterial hypertension, hypercholesterolemia,
and obesity also show strong and at least partially inde-
pendent genetic components [1]. To date, efforts to iden-
tify the genes underlying these traits have had only limited
success, and only a few positive findings have been repli-
cated (e.g., [2-4]).
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A particular complication to the identification of novel
CAD genes is the high correlation among cardiovascular
risk factors. In fact, because high blood pressure, altered
lipid levels, obesity, and diabetes so frequently occur
together, they are sometimes collectively referred to as the
metabolic syndrome or syndrome X (MSX [5]). Because
MSX was initially defined for clinicians, the syndrome and
its various component traits were dichotomized, although
each is more informatively viewed as a quantitative trait.
While there have been many studies of each MSX trait sep-
arately [2,6], only a few studies have considered the syn-
drome itself, either as a whole or broken into factors, in
quantitative trait linkage or association analysis (e.g., [7-
9]).
Our study utilizes genotype and phenotype data from the
Framingham Heart Study, made available for the Genetic
Analysis Workshop 13 (GAW13), to search for quantita-
tive trait loci (QTL) underlying MSX in this large, carefully
followed sample. Specifically, we defined five MSX-
related quantitative traits across the life-span (systolic
blood pressure (SBP), triglycerides (TGL), high-density
lipoprotein cholesterol (HDL), blood sugar (BS), and
body mass index (BMI), calculated their heritabilities, and
performed whole-genome scans on each. We then com-
bined the individual quantitative traits into a composite
quantitative trait, the metabolic syndrome score (MSS),
and calculated its heritability and scanned the genome for
linkage.
Methods
Description of the data set
From the data provided for Problem 1 in the GAW13 data
set (Framingham Heart Study), we selected the 1617 indi-
viduals between the ages of 30 and 69 with at least one
examination cycle in which there was complete data for
all five component measures (SBP, TGL, HDL, BS, and
BMI). These age limits were chosen because our prelimi-
nary analyses, consistent with the cardiovascular litera-
ture, suggested that heritability was greatest in this
interval, and because the data tended to be sparse at lower
and higher ages. We used all available complete observa-
tions (examination cycles with complete data on all 5
traits) from age 30 to 69 for each individual, and devel-
oped a life-span measure for each trait, as described
below. The number of complete observations available for
each subject varied from one (n = 116) to five (n = 524),
with a mean of 3.7 observations per subject. Of these
1617 individuals, 1313 also had genotype data available.
Estimation of the phenotypes
For each trait, we began by transforming as needed to
achieve an approximately normal distribution [10]. SBP,
HDL, and BMI (calculated as [weight (kg)/height2 (m)]
were approximately normally distributed, so we used the
raw values. TGL was log-transformed to better approxi-
mate a normal distribution. BS was markedly skewed and
leptokurtotic, so we followed the procedure used by Meigs
et al. [11] (ranking the measurement across all observa-
tions, and then standardizing the resulting ranks by sub-
tracting out their mean and dividing by their standard
deviation). Note that all available blood sugar measure-
ments, whether fasting or not, were included in order to
maximize the number of individuals with complete data
in each family. We also ran all analyses using only those
measurements explicitly noted to be fasting (all measure-
ments for Cohort 2, and measurements 10–12 [for which
we took the average in order to minimize missing data]
for Cohort 1). This resulted in only minor differences
from the results reported here, perhaps related to our use
of ranks rather than actual observed values. In addition, it
should be noted that the fasting BS values reported for
exams 10–12 for Cohort 1 were actually higher on average
than those reported for the other non-fasting exams.
For each of these variables, we then adjusted for alcohol
and smoking in linear regression analyses of each trait per-
formed separately for males and females at each age. Age
was considered in 1-year bands to increase the precision
of our analyses, and to ensure that each subject contrib-
uted only once to these values. Alcohol consumption was
categorized as 0, 0.1–12, 13–25, 26–40, and >40 g/day to
allow for non-linear effects, while the number of ciga-
rettes smoked per day was entered as a continuous trait.
The residuals from these linear regression analyses were
then standardized, again within groups defined by gender
and age, by subtracting the age and gender specific mean
and dividing by the age and gender-specific standard
error. Since the resultant residuals were approximately
normally distributed, the standardization process yielded
trait values that followed a N ~ (0, 1) distribution. We
then averaged each gender- and age-standardized pheno-
type over all available visits to obtain a "life-span" esti-
mate for each subject. We also calculated a corresponding
average age at which subjects contributed data.
To generate an MSS for each of the subjects' available
observations, we combined the standardized residuals for
each component trait prior to the calculation of life-span
averages as follows: [MSS = SBP + TGL + BS + BMI - HDL].
HDL was subtracted from the score because it is protective
against CAD, and tends to be inversely correlated with the
other component traits; thus, lower  HDL values corre-
spond to a higher MSS. These resulting sums were then
averaged to create a lifespan MSS. The MSS as calculated
yields a lifetime score for each individual that is an indi-
cation of how his or her MSS deviates from the age and
gender mean.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S96
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Estimation of heritability and linkage analysis
Heritability estimates were calculated, controlling for
average age and gender at which subjects contributed
data, for each of the component traits, and for the MSS
composite trait, using the variance-components methods
implemented in SOLAR [12]. We then performed two-
point and multi-point quantitative trait linkage analysis,
also using SOLAR. Individuals without genotype informa-
tion were included in the linkage analyses, because the
proportion of marker alleles shared identically by descent
was estimated for both genotyped and non-genotyped
individuals in pedigrees.
Results
Descriptive statistics
Descriptive statistics for raw values of each of the compo-
nent traits, prior to covariate adjustment and standardiza-
tion procedures, are provided in Table 1. These figures
demonstrate a broad range consistent with published data
on the Framingham Study. MSS, as a sum of standard
deviations from the mean for each of the component
traits, is not readily interpretable beside these raw values,
so it is not included in Table 1: it exhibited a mean of 0.15,
a standard deviation of 2.7, and a range of -7.3 to 11.8.
Heritability estimates
Heritability estimates for the individual component traits
were all fairly high, ranging from 0.39 to 0.62, and MSS
was at the high end of this range at 0.61 (Table 2). All her-
itability estimates were highly statistically significant (p <
0.00001).
Multi-point linkage analysis
For each phenotype, the maximum multi-point LOD
score and its cytogenetic and chromosomal location are
presented in Table 2. While we observed no statistically
significant linkage for any trait, there were two locations
with suggestive linkage by Lander and Kruglyak's criteria
[13]: a LOD of 2.4 for BS on chromosome 5pter, and a
LOD of 2.3 for HDL on chromosome 15p13-q11. There
was also a LOD of 2.1 for HDL on chromosome 7p14.
There was essentially no linkage signal for MSS in any of
these locations, but MSS did give LOD scores of 1.82 on
12q13 (a signal also seen with BMI) and 1.79 on chromo-
some 1q42 (a signal also seen with SBP). The overall
results are summarized in Figures 1 and 2. The two-point
results (data not shown) were consistent with the multi-
point findings.
Discussion
In our full-genome scan for novel QTLs underlying MSX
and its component traits in the Framingham Heart Study,
we found evidence for at least two 'suggestive' loci-a LOD
of 2.3 for HDL on 15p13-q11 and a LOD of 2.4 for BS on
5pter, and one locus just short of this threshold-a LOD of
2.1 for HDL on 7p14. Interestingly, these three peaks do
not map close to linkage signals observed in recent studies
of MSX, BS, or HDL in the Framingham data (e.g.
[11,14,15]) or in a variety of independent samples (e.g.
Table 1: Descriptive statistics of each of the component phenotypes.
Trait Mean Std. Deviation Minimum Maximum
SBP (mm Hg) 122 8 86 195
H D L  ( m g / d l ) 5 01 31 79 3
TGL (mg/dl) 120 84 15 1205
B S  ( m g / d l ) 9 71 86 1 3 0 2
BMI (kg/m2)2 6 4 . 6 1 6 4 9
Table 2: Heritability estimates, maximum multi-point LOD scores, and their location for each quantitative phenotype.
Trait Heritability Max LOD Chr. Location (cM) MarkerA
MSS 0.61 1.82 12q13 63 GATA5A09
SBP 0.48 1.93 1p31 97 GATA61A06
HDL 0.62 2.27 15p13-q11 1 GATA81F03
TGL 0.56 1.85 3p26 9 GATA22G12
BS 0.39 2.37 5pter 0 028xb12
BMI 0.51 1.86 12q21 85 GATA26D02
AClosest marker to the observed multi-point LOD score peak.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S96
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[1,6,16]). However, the location of the maximum signal
we found for MSS-a LOD of 1.82 on 12q13-mapped rela-
tively close to locations found in other studies involving
type 2 diabetes-related phenotypes (e.g. [17-19]). In addi-
tion, we did observe more minor signals that were consist-
ent with prior reports, particularly for BS (e.g., the LOD of
1.77 on chromosome 1q42 for BS coincides with earlier
results from the Framingham sample [11]). Discrepancies
between our findings and prior studies may be due to dif-
ferences in defining the individual quantitative pheno-
types (e.g., transformation, averaging of longitudinal
data), different methods of generating combined pheno-
types (e.g., crude sum vs. factor analysis vs. other weight-
ing schemes), different inclusion criteria (e.g., using a
broad but not complete age range and including only
examination cycles with complete data on all five traits),
or chance variation. Of note, while averaging across visits
within subjects was intended to incorporate some of the
richness of the longitudinal data, it may actually have led
to a decrease in some signals.
Conclusions
Despite its high heritability, the relatively crude estimate
of a composite metabolic syndrome variable (MSS) did
not increase our ability to detect or localize linkage peaks
in this sample. Not surprisingly, the only two noteworthy
signals for MSS appear to be driven by linkages to its com-
ponent traits (BMI and SBP on chromosome 12q13, and
BS on chromosome 1q42). Nonetheless, we feel that
similar strategies, bucking the current trend toward disag-
gregation of complex phenotypes, may merit further
exploration in this and other settings with complex causal
pathways marked by extensive correlation among
intermediate causes. If this approach is to succeed, it will
be critical to develop weighting schemes that more accu-
rately represent the contribution of each trait to the over-
all syndrome.
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